Profile data is unavailable for this security.
About the company
VIVA Biotech Holdings is a China-based investment holding company. The Company is principally engaged in the provision of the structure-based drug discovery services to biotechnology and pharmaceutical customers worldwide for their pre-clinical stage innovative drug development. The Company’s core technologies include structure-based drug discovery (SBDD) platform, fragment-based drug discovery (FBDD) platform, affinity selection mass spectrometry (ASMS) screening platform and membrane protein targeted drug discovery platform. The Company operates its businesses mainly in the United States, China, Europe and other regions.
- Revenue in HKD (TTM)2.32bn
- Net income in HKD-125.05m
- Incorporated2008
- Employees2.08k
- LocationVIVA Biotech Holdings735 Ziping RoadZhoupu Town, Pudong New DistrictShanghai 201318ChinaCHN
- Phone+86 2 160893288
- Fax+86 2 158243936
- Websitehttps://www.vivabiotech.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jbm (Healthcare) Ltd | 610.30m | 97.99m | 783.78m | 258.00 | 8.65 | 0.8358 | 5.27 | 1.28 | 0.1087 | 0.1087 | 0.6786 | 1.12 | 0.4406 | 5.88 | 4.10 | 2,000,994.00 | 7.56 | 3.33 | 9.04 | 4.93 | 47.70 | 45.97 | 17.17 | 10.97 | 1.45 | 22.15 | 0.1211 | 13.81 | 28.11 | 14.51 | 131.90 | 6.14 | -5.09 | -- |
| Jilin Provnc Hnn Chnglng Bio-pharm CoLtd | 906.28m | 159.61m | 823.57m | 848.00 | 5.16 | 0.5166 | 6.74 | 0.9087 | 0.2849 | 0.2849 | 1.62 | 2.85 | 0.3587 | 2.18 | 2.94 | 1,068,731.00 | 6.32 | 7.67 | 9.12 | 10.48 | 69.40 | 78.79 | 17.61 | 20.68 | 1.51 | -- | 0.0515 | 7.22 | -0.0049 | 5.38 | -23.43 | -1.67 | -1.14 | -- |
| Brii Biosciences Ltd | 664.46k | -188.28m | 832.03m | 128.00 | -- | 0.2476 | -- | 1,252.17 | -0.2588 | -0.2588 | 0.0009 | 4.61 | 0.0002 | -- | -- | 5,191.13 | -5.60 | -- | -5.84 | -- | -- | -- | -29,881.69 | -- | -- | -- | 0.001 | -- | -98.80 | -- | 63.90 | -- | -- | -- |
| Zhongzhi Pharmaceutical Holdings Ltd | 2.21bn | 175.30m | 863.60m | 2.64k | 4.83 | 0.7648 | 3.01 | 0.3912 | 0.207 | 0.207 | 2.61 | 1.31 | 1.12 | 2.53 | 10.54 | 835,225.40 | 8.95 | 7.69 | 14.15 | 11.75 | 59.73 | 60.44 | 8.01 | 6.73 | 0.894 | -- | 0.1424 | 42.46 | 12.26 | 12.41 | 53.00 | 13.86 | 17.65 | 3.22 |
| Fusen Pharmaceutical Co Ltd | 609.12m | -39.07m | 877.45m | 1.15k | -- | 1.45 | -- | 1.44 | -0.0523 | -0.0523 | 0.8099 | 0.8092 | 0.4199 | 1.95 | 8.36 | 530,591.80 | -2.69 | 0.9678 | -5.54 | 1.74 | 52.95 | 51.95 | -6.42 | 2.59 | 0.6096 | 0.756 | 0.3797 | 27.95 | 15.02 | 4.13 | -4.83 | -- | 0.2124 | -- |
| JW (Cayman) Therapeutics Co Ltd | 187.23m | -827.08m | 920.34m | 398.00 | -- | 0.5049 | -- | 4.92 | -2.01 | -2.01 | 0.455 | 4.40 | 0.0704 | 1.68 | 65.54 | 470,428.30 | -31.11 | -39.77 | -35.21 | -44.00 | 50.74 | -- | -441.74 | -1,316.81 | 3.86 | -47.82 | 0.1592 | -- | 19.32 | -- | 9.23 | -- | -19.87 | -- |
| Hbm Holdings Ltd | 699.02m | 178.05m | 1.01bn | 177.00 | 5.45 | 1.03 | 4.74 | 1.45 | 0.2422 | 0.2422 | 0.9524 | 1.28 | 0.3886 | 3.90 | 3.01 | 3,949,263.00 | 9.88 | -54.61 | 14.13 | -66.04 | 97.73 | 97.81 | 25.43 | -400.28 | 3.28 | 6.98 | 0.3556 | -- | 120.13 | 127.06 | 116.61 | -- | -12.62 | -- |
| Sunho Biologics Inc | -100.00bn | -100.00bn | 1.05bn | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -155.25 | -- | -- | -- |
| Ascletis Pharma Inc | 60.95m | -155.85m | 1.07bn | 219.00 | -- | 0.4382 | -- | 17.61 | -0.1465 | -0.1465 | 0.0567 | 2.42 | 0.022 | 2.30 | 3.86 | 278,309.80 | -5.62 | -6.43 | -5.91 | -6.64 | 45.92 | 35.67 | -255.70 | -243.38 | 16.54 | -6.09 | 0.0036 | -- | 4.63 | -19.39 | 54.04 | -- | -20.44 | -- |
| VIVA Biotech Holdings | 2.32bn | -125.05m | 1.21bn | 2.08k | -- | 0.302 | 10.09 | 0.5214 | -0.0636 | -0.0636 | 1.20 | 1.85 | 0.2805 | 4.84 | 5.21 | 1,117,671.00 | -1.30 | -1.39 | -1.79 | -1.68 | 34.26 | 34.81 | -4.63 | -5.44 | 1.15 | 1.00 | 0.3412 | -- | -9.42 | 59.31 | 78.03 | -- | 31.98 | -- |
| Jacobson Pharma Corporation Ltd | 1.68bn | 212.16m | 1.24bn | 1.59k | 5.57 | 0.5198 | 3.13 | 0.7368 | 0.1112 | 0.1409 | 0.8822 | 1.19 | 0.3722 | 2.87 | 7.50 | 940,829.50 | 5.16 | 4.91 | 6.61 | 6.60 | 42.05 | 41.81 | 13.85 | 14.32 | 1.01 | 5.62 | 0.3646 | 35.97 | 11.91 | 2.89 | 41.30 | 4.42 | -6.22 | 6.39 |
| CStone Pharmaceuticals | 499.52m | -395.48m | 1.39bn | 230.00 | -- | 2.82 | -- | 2.78 | -0.3135 | -0.3135 | 0.3955 | 0.3831 | 0.2811 | 2.44 | 3.72 | 2,171,846.00 | -22.25 | -54.76 | -48.85 | -81.68 | 65.60 | -- | -79.17 | -301.62 | 1.44 | -- | 0.4431 | -- | -3.64 | -- | 59.32 | -- | 52.42 | -- |
| Jacobio Pharmaceuticals Group Co Ltd | 68.41m | -386.75m | 1.40bn | 301.00 | -- | 1.21 | -- | 20.49 | -0.5003 | -0.5003 | 0.0885 | 1.46 | 0.0419 | -- | 5.21 | 227,264.10 | -23.66 | -45.76 | -26.86 | -49.30 | 5.04 | -- | -565.36 | -372.22 | -- | -- | 0.1636 | -- | -33.66 | -- | 3.43 | -- | 19.18 | -- |
| Essex Bio-Technology Ltd | 1.71bn | 275.26m | 1.41bn | 1.48k | 5.29 | 0.7317 | 4.20 | 0.8248 | 0.4689 | 0.4689 | 2.87 | 3.39 | 0.6161 | 2.28 | 3.35 | 1,152,300.00 | 9.94 | 11.20 | 13.21 | 14.73 | 90.20 | 86.01 | 16.13 | 19.77 | 1.46 | -- | 0.1326 | 16.16 | 29.51 | 7.72 | 22.11 | 3.56 | 7.29 | 7.39 |
| Wuhan YZY Biopharma Co Ltd | 0.00 | -206.45m | 1.45bn | 123.00 | -- | 10.55 | -- | -- | -1.11 | -1.11 | 0.00 | 0.7092 | -- | -- | -- | 0.00 | -- | -- | -- | -- | -- | -- | -- | -- | 1.41 | -100.12 | 0.4138 | -- | -- | -- | -1.50 | -- | -- | -- |
| Mabpharm Ltd | 93.87m | -225.46m | 1.51bn | 347.00 | -- | 6.82 | -- | 16.04 | -0.0547 | -0.0547 | 0.0228 | 0.0536 | 0.0893 | 0.1176 | 6.02 | 270,507.70 | -21.44 | -21.42 | -28.92 | -27.49 | 86.32 | -- | -240.19 | -486.40 | 0.7596 | -19.03 | 0.5591 | -- | 55.87 | -- | 0.694 | -- | -26.85 | -- |
Data as of Jun 14 2024. Currency figures normalised to VIVA Biotech Holdings's reporting currency: Hong Kong Dollar HKD
1.20%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Dimensional Fund Advisors LPas of 06 Jun 2024 | 10.27m | 0.48% |
| Bosera Asset Management Co., Ltd.as of 31 Dec 2022 | 8.30m | 0.38% |
| Norges Bank Investment Managementas of 31 Dec 2023 | 3.26m | 0.15% |
| American Century Investment Management, Inc.as of 06 Jun 2024 | 1.42m | 0.07% |
| Dimensional Fund Advisors Ltd.as of 30 Apr 2024 | 925.49k | 0.04% |
| SSgA Funds Management, Inc.as of 06 Jun 2024 | 887.50k | 0.04% |
| Schroder Investment Management North America, Inc.as of 28 Feb 2021 | 442.50k | 0.02% |
| China Universal Asset Management Co., Ltd.as of 31 Dec 2023 | 155.50k | 0.01% |
| Macquarie Investment Management Global Ltd.as of 30 Apr 2023 | 120.00k | 0.01% |
| First Seafront Fund Management Co., Ltd.as of 31 Dec 2023 | 105.50k | 0.01% |
More ▼
Data from 31 Dec 2023 - 13 Jun 2024Source: FactSet Research Systems Inc.
